研究業績
The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma.Tsutsumi S, Momiyama K, Ichinoe M, Kato T, Mogi S, Miyamoto S, Murakumo Y, Yamashita T. Anticancer Res. 2022 Apr;42(4):2061-2070. doi: 10.21873/anticanres.15687. PMID: 35347029
Woo J, Haradome H, Adachi K, Iwai T, Nishizawa N, Murakumo Y, Kusano C, Kumamoto Y, Inoue Y, Ojiri H. Abdom Radiol (NY). 2022 Feb 16. doi: 10.1007/s00261-022-03442-3. Online ahead of print. PMID: 35171320
Adachi K, Sakurai Y, Ichinoe M, Tadehara M, Tamaki A, Kesen Y, Kato T, Mii S, Enomoto A, Takahashi M, Koizumi W, Murakumo Y. Virchows Arch. 2021 Nov 11. doi: 10.1007/s00428-021-03230-2. Online ahead of print. PMID: 34762199
Upregulation of REV7 correlates with progression of malignant melanoma.
Hoshino A, Nakayama C, Jiang SX, Sakurai Y, Kato T, Numata Y, Umezawa A, Ichinoe M, Murakumo Y. Pathol Int. 2022 Jan;72(1):14-24. doi: 10.1111/pin.13174. Epub 2021 Oct 12. PMID: 34637584
Yanagisawa N, Satoh T, Tabata KI, Tsumura H, Nasu Y, Watanabe M, Thompson TC, Okayasu I, Murakumo Y, Baba S, Iwamura M. Asian J Urol. 2021 Jul;8(3):280-288. doi: 10.1016/j.ajur.2020.06.004. Epub 2020 Jun 16. PMID: 34401335
Kusuhara S, Igawa S, Ichinoe M, Nagashio R, Kuchitsu Y, Hiyoshi Y, Shiomi K, Murakumo Y, Saegusa M, Satoh Y, Sato Y, Naoki K. Thorac Cancer. 2021 May;12(10):1570-1578. doi: 10.1111/1759-7714.13945. Epub 2021 Apr 1. PMID: 33793071
Sanoyama I, Sakurai Y, Ichinoe M, Hoshino A, Kesen Y, Kato T, Numata Y, Umezawa A, Jiang SX, Murakumo Y. Pathol Int. 2021 Jan;71(1):15-23. doi: 10.1111/pin.13040. Epub 2020 Oct 28. PMID: 33112501
Taki T, Shiraki Y, Enomoto A, Weng L, Chen C, Asai N, Murakumo Y, Yokoi K, Takahashi M, Mii S. Cancer Sci. 2020 Dec;111(12):4616-4628. doi: 10.1111/cas.14673. Epub 2020 Oct 24. PMID: 33007133
Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer.
Ichinoe M, Mikami T, Yanagisawa N, Yoshida T, Hana K, Endou H, Okayasu I, Sengoku N, Ogata H, Saegusa M, Shibuya K, Murakumo Y. J Clin Pathol. 2021 Sep;74(9):589-595. doi: 10.1136/jclinpath-2020-206457. Epub 2020 Sep 9. PMID: 32907912
Hamamura K, Hotta H, Murakumo Y, Shibuya H, Kondo Y, Furukawa K. J Oral Sci. 2020 Sep 26;62(4):393-396. doi: 10.2334/josnusd.19-0513. Epub 2020 Jul 17. PMID: 32684574
Sakurai Y, Ichinoe M, Yoshida K, Nakazato Y, Saito S, Satoh M, Nakada N, Sanoyama I, Umezawa A, Numata Y, Shi-Xu J, Ichihara M, Takahashi M, Murakumo Y. Cancer Lett. 2020 Oct 1;489:100-110. doi: 10.1016/j.canlet.2020.06.001. Epub 2020 Jun 15. PMID: 32553781
Nagashio R, Kuchitsu Y, Igawa S, Kusuhara S, Naoki K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Sato Y. Biomed Res. 2020;41(3):149-159. doi: 10.2220/biomedres.41.149. PMID: 32522932
Nakada N, Mikami T, Horie K, Nagashio R, Sakurai Y, Sanoyama I, Yoshida T, Sada M, Kobayashi K, Sato Y, Okayasu I, Murakumo Y. Pathol Int. 2020 Aug;70(8):523-532. doi: 10.1111/pin.12949. Epub 2020 May 14. PMID: 32410301
Kuchitsu Y, Nagashio R, Igawa S, Kusuhara S, Tsuchiya B, Ichinoe M, Satoh Y, Naoki K, Murakumo Y, Saegusa M, Sato Y. Biomed Res. 2020;41(1):53-65. doi: 10.2220/biomedres.41.53. PMID: 32092740
Satoh Y, Matsuo Y, Kuba T, Yamashita K, Sawano M, Tozaka S, Yamazaki H, Sonoda D, Mikubo M, Naito M, Matsui Y, Shiomi K, Yoshida T, Murakumo Y. Virchows Arch. 2020 May;476(5):753-762. doi: 10.1007/s00428-019-02692-9. Epub 2019 Dec 10. PMID: 31823000
Hiyoshi Y, Sato Y, Ichinoe M, Nagashio R, Hagiuda D, Kobayashi M, Kusuhara S, Igawa S, Shiomi K, Goshima N, Murakumo Y, Saegusa M, Satoh Y, Masuda N, Naoki K. Thorac Cancer. 2019 Nov;10(11):2142-2151. doi: 10.1111/1759-7714.13200. Epub 2019 Oct 3. PMID: 31583841
Mii S, Enomoto A, Shiraki Y, Taki T, Murakumo Y, Takahashi M. Pathol Int. 2019 May;69(5):249-259. doi: 10.1111/pin.12798. Epub 2019 Jun 20. PMID: 31219232 Review.
Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma.
Hagiuda D, Nagashio R, Ichinoe M, Tsuchiya B, Igawa S, Naoki K, Satoh Y, Murakumo Y, Saegusa M, Sato Y. Biomed Res. 2019;40(1):17-27. doi: 10.2220/biomedres.40.17. PMID: 30787260
Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer.
Yanagita K, Nagashio R, Jiang SX, Kuchitsu Y, Hachimura K, Ichinoe M, Igawa S, Fukuda E, Goshima N, Satoh Y, Murakumo Y, Saegusa M, Sato Y. Am J Pathol. 2018 Jun;188(6):1328-1333. doi: 10.1016/j.ajpath.2018.03.007. Epub 2018 May 8. PMID: 29751934
Qi R, Dong F, Liu Q, Murakumo Y, Liu J. J Transl Med. 2018 Apr 6;16(1):88. doi: 10.1186/s12967-018-1461-3. PMID: 29625613
Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.
Matsumoto T, Nagashio R, Ryuge S, Igawa S, Kobayashi M, Fukuda E, Goshima N, Ichinoe M, Jiang SX, Satoh Y, Masuda N, Murakumo Y, Saegusa M, Sato Y. Pathol Int. 2018 Apr;68(4):232-240. doi: 10.1111/pin.12646. Epub 2018 Feb 12. PMID: 29431238
Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma.
Kobayashi M, Nagashio R, Saito K, Aguilar-Bonavides C, Ryuge S, Katono K, Igawa S, Tsuchiya B, Jiang SX, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Sato Y. Hum Pathol. 2018 Apr;74:148-155. doi: 10.1016/j.humpath.2018.01.001. Epub 2018 Jan 7. PMID: 29320753
Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N.
Katono K, Sato Y, Kobayashi M, Saito K, Nagashio R, Ryuge S, Igawa S, Nakashima H, Shiomi K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Masuda N. Oncol Res Treat. 2017;40(10):594-602. doi: 10.1159/000478100. Epub 2017 Sep 19. PMID: 28950283
Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.
Shiraki Y, Mii S, Enomoto A, Momota H, Han YP, Kato T, Ushida K, Kato A, Asai N, Murakumo Y, Aoki K, Suzuki H, Ohka F, Wakabayashi T, Todo T, Ogawa S, Natsume A, Takahashi M. J Pathol. 2017 Dec;243(4):468-480. doi: 10.1002/path.4981. Epub 2017 Nov 1. PMID: 28888050
Ryuge S, Sato Y, Nagashio R, Hiyoshi Y, Katono K, Igawa S, Nakashima H, Shiomi K, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Masuda N. PLoS One. 2017 Mar 30;12(3):e0173886. doi: 10.1371/journal.pone.0173886. eCollection 2017. PMID: 28358810 Free PMC article.
Igawa S, Sato Y, Ryuge S, Ichinoe M, Katono K, Hiyoshi Y, Otani S, Nagashio R, Nakashima H, Katagiri M, Sasaki J, Murakumo Y, Satoh Y, Masuda N.
Igawa S, Ryuge S, Ichinoe M, Nakashima H, Otani S, Nakahara Y, Fukui T, Sasaki J, Kubota M, Katagiri M, Murakumo Y, Satoh Y, Sato Y, Masuda N. Oncol Res Treat. 2017;40(1-2):7-13. doi: 10.1159/000455147. Epub 2017 Jan 25. PMID: 28118631
Yokoyama M, Ichinoe M, Okina S, Sakurai Y, Nakada N, Yanagisawa N, Jiang SX, Numata Y, Umezawa A, Miyazaki K, Higashihara M, Murakumo Y. Int J Hematol. 2017 May;105(5):614-622. doi: 10.1007/s12185-016-2173-1. Epub 2016 Dec 28. PMID: 28032275
Sunagawa M, Mii S, Enomoto A, Kato T, Murakumo Y, Shiraki Y, Asai N, Asai M, Nagino M, Takahashi M. Oncotarget. 2016 Dec 13;7(50):82836-82850. doi: 10.18632/oncotarget.12653. PMID: 27756876 Free PMC article.
CD109 is a component of exosome secreted from cultured cells.
Sakakura H, Mii S, Hagiwara S, Kato T, Yamamoto N, Hibi H, Takahashi M, Murakumo Y. Biochem Biophys Res Commun. 2016 Jan 22;469(4):816-22. doi: 10.1016/j.bbrc.2015.12.063. Epub 2015 Dec 18. PMID: 26707640
Okina S, Yanagisawa N, Yokoyama M, Sakurai Y, Numata Y, Umezawa A, Higashihara M, Murakumo Y. Int J Hematol. 2015 Dec;102(6):662-9. doi: 10.1007/s12185-015-1880-3. Epub 2015 Oct 8. PMID: 26449786
Ichinoe M, Yanagisawa N, Mikami T, Hana K, Nakada N, Endou H, Okayasu I, Murakumo Y. Pathol Res Pract. 2015 Jul;211(7):533-8. doi: 10.1016/j.prp.2015.03.007. Epub 2015 Apr 7. PMID: 25908107
Yanagisawa N, Satoh T, Hana K, Ichinoe M, Nakada N, Endou H, Okayasu I, Murakumo Y. Cancer Biomark. 2015;15(4):365-74. doi: 10.3233/CBM-150486. PMID: 25835180
Nagashio R, Ueda J, Ryuge S, Nakashima H, Jiang SX, Kobayashi M, Yanagita K, Katono K, Satoh Y, Masuda N, Murakumo Y, Hachimura K, Sato Y. Sci Rep. 2015 Mar 3;5:8649. doi: 10.1038/srep08649. PMID: 25733373 Free PMC article.
Zhang JM, Murakumo Y, Hagiwara S, Jiang P, Mii S, Kalyoncu E, Saito S, Suzuki C, Sakurai Y, Numata Y, Yamamoto T, Takahashi M. Biochem Biophys Res Commun. 2015 Apr 3;459(2):252-258. doi: 10.1016/j.bbrc.2015.02.093. Epub 2015 Feb 25. PMID: 25724945 Free article.
Weng L, Enomoto A, Miyoshi H, Takahashi K, Asai N, Morone N, Jiang P, An J, Kato T, Kuroda K, Watanabe T, Asai M, Ishida-Takagishi M, Murakumo Y, Nakashima H, Kaibuchi K, Takahashi M. EMBO J. 2014 Sep 17;33(18):2098-112. doi: 10.15252/embj.201488289. Epub 2014 Jul 24. PMID: 25061227 Free PMC article.
Yanagisawa N, Hana K, Nakada N, Ichinoe M, Koizumi W, Endou H, Okayasu I, Murakumo Y. Cancer Med. 2014 Oct;3(5):1246-55. doi: 10.1002/cam4.272. Epub 2014 Jun 2. PMID: 24890221 Free PMC article.
TRIM27/MRTF-B-dependent integrin β1 expression defines leading cells in cancer cell collectives.
Kato T, Enomoto A, Watanabe T, Haga H, Ishida S, Kondo Y, Furukawa K, Urano T, Mii S, Weng L, Ishida-Takagishi M, Asai M, Asai N, Kaibuchi K, Murakumo Y, Takahashi M. Cell Rep. 2014 May 22;7(4):1156-67. doi: 10.1016/j.celrep.2014.03.068. Epub 2014 May 1. PMID: 24794433
Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells.
Niimi K, Murakumo Y, Watanabe N, Kato T, Mii S, Enomoto A, Asai M, Asai N, Yamamoto E, Kajiyama H, Shibata K, Kikkawa F, Takahashi M. Cancer Sci. 2014 May;105(5):545-52. doi: 10.1111/cas.12390. Epub 2014 Apr 7. PMID: 24597627 Free PMC article.
Sakakura H, Murakumo Y, Mii S, Hagiwara S, Kato T, Asai M, Hoshino A, Yamamoto N, Sobue S, Ichihara M, Ueda M, Takahashi M. PLoS One. 2014 Jan 6;9(1):e83385. doi: 10.1371/journal.pone.0083385. eCollection 2014. PMID: 24400073 Free PMC article.
Masuzawa M, Mikami T, Numata Y, Tokuyama W, Masuzawa M, Murakumo Y, Okayasu I, Katsuoka K. Hum Pathol. 2013 Dec;44(12):2751-9. doi: 10.1016/j.humpath.2013.07.022. Epub 2013 Oct 11. PMID: 24125743
The REV7 subunit of DNA polymerase ζ is essential for primordial germ cell maintenance in the mouse.
Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Expression of CD109 in human cancer.
Linkage of the athymic nude locus with the myeloperoxidase locus in the rat.
Chromosomal mapping of genetic locus associated with thymus-size enlargement in BUF/Mna rats.